Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group

被引：10

作者：

Bond, Marinde J. G. ^{[1
]}

Kuiper, Babette I. ^{[2
,3
,24
]}

Bolhuis, Karen ^{[4
,5
]}

Komurcu, Aysun ^{[6
]}

van Amerongen, Martinus J. ^{[7
]}

Chapelle, Thiery ^{[8
]}

Dejong, Cornelis H. C. ^{[9
,10
]}

Engelbrecht, Marc R. W. ^{[11
]}

Gerhards, Michael F. ^{[12
]}

Grunhagen, Dirk J. ^{[13
]}

van Gulik, Thomas ^{[2
,3
]}

Hermans, John J. ^{[14
]}

de Jong, Koert P. ^{[15
]}

Klaase, Joost M. ^{[15
]}

Kok, Niels F. M. ^{[16
]}

Leclercq, Wouter K. G. ^{[17
]}

Liem, Mike S. L. ^{[18
]}

van Lienden, Krijn P. ^{[19
]}

Molenaar, I. Quintus ^{[20
]}

Neumann, Ulf P. ^{[9
,10
]}

Patijn, Gijs A. ^{[21
]}

Rijken, Arjen M. ^{[22
]}

Ruers, Theo M. ^{[16
]}

Verhoef, Cornelis ^{[13
]}

de Wilt, Johannes H. W. ^{[23
]}

Kazemier, Geert ^{[2
,3
,24
]}

May, Anne M. ^{[1
]}

Punt, Cornelis J. A. ^{[1
,4
]}

Swijnenburg, Rutger-Jan ^{[2
,3
,24
]}

机构：

[1] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands

[2] Univ Amsterdam, Dept Surg, Amsterdam UMC, Amsterdam, Netherlands

[3] Vrije Univ Amsterdam, Amsterdam, Netherlands

[4] Amsterdam UMC, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam, Netherlands

[5] Netherlands Canc Inst, Dept Gastrointestinal Oncol, Amsterdam, Netherlands

[6] Netherlands Comprehens Canc Ctr, Utrecht, Netherlands

[7] Sint Maartensklin, Dept Radiol, Nijmegen, Netherlands

[8] Antwerp Univ Hosp, Dept Hepatobiliary Transplantat & Endocrine Surg, Antwerp, Belgium

[9] Maastricht Univ, Dept Surg, Med Ctr, Maastricht, Netherlands

[10] Univ Klinikum Aachen, Aachen, Germany

[11] Amsterdam UMC, Dept Radiol & Nucl Med, Amsterdam, Netherlands

[12] OLVG Hosp, Dept Surg, Amsterdam, Netherlands

[13] Erasmus MC Canc Inst, Dept Surg, Rotterdam, Netherlands

[14] Radboud Univ Nijmegen, Dept Radiol, Med Ctr, Nijmegen, Netherlands

[15] Univ Med Ctr Groningen, Dept Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands

[16] Netherlands Canc Inst, Dept Surg, Amsterdam, Netherlands

[17] Maxima Med Ctr, Dept Surg, Veldhoven, Netherlands

[18] Med Spectrum Twente, Dept Surg, Enschede, Netherlands

[19] St Antonius Hosp, Dept Radiol, Nieuwegein, Netherlands

[20] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands

[21] Isala Hosp, Dept Surg, Zwolle, Netherlands

[22] Amphia Hosp, Dept Surg, Breda, Netherlands

[23] Radboud Univ Nijmegen, Dept Surg, Med Ctr, Nijmegen, Netherlands

[24] Canc Ctr Amsterdam, Amsterdam, Netherlands

来源：

ANNALS OF SURGICAL ONCOLOGY | 2023年 / 30卷 / 09期

关键词：

CHEMOTHERAPY; PLUS; BEVACIZUMAB; STRATEGIES; OUTCOMES; SURGERY;

D O I：

10.1245/s10434-023-13510-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background Consensus on resectability criteria for colorectal cancer liver metastases (CRLM) is lacking, resulting in differences in therapeutic strategies. This study evaluated variability of resectability assessments and local treatment plans for patients with initially unresectable CRLM by the liver expert panel from the randomised phase III CAIRO5 study.Methods The liver panel, comprising surgeons and radiologists, evaluated resectability by predefined criteria at baseline and 2-monthly thereafter. If surgeons judged CRLM as resectable, detailed local treatment plans were provided. The panel chair determined the conclusion of resectability status and local treatment advice, and forwarded it to local surgeons.Results A total of 1149 panel evaluations of 496 patients were included. Intersurgeon disagreement was observed in 50% of evaluations and was lower at baseline than follow-up (36% vs. 60%, p < 0.001). Among surgeons in general, votes for resectable CRLM at baseline and follow-up ranged between 0-12% and 27-62%, and for permanently unresectable CRLM between 3-40% and 6-47%, respectively. Surgeons proposed different local treatment plans in 77% of patients. The most pronounced intersurgeon differences concerned the advice to proceed with hemihepatectomy versus parenchymal-preserving approaches. Eighty-four percent of patients judged by the panel as having resectable CRLM indeed received local treatment. Local surgeons followed the technical plan proposed by the panel in 40% of patients.Conclusion Considerable variability exists among expert liver surgeons in assessing resectability and local treatment planning of initially unresectable CRLM. This stresses the value of panel-baseddecisions, and the need for consensus guidelines on resectability criteria and technical approach to prevent unwarranted variability in clinical practice.

引用

页码：5376 / 5385

页数：10

共 50 条

[1] ASO Visual Abstract: Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases—Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group
Marinde J. G. Bond
Babette I. Kuiper
Karen Bolhuis
Aysun Komurcu
Martinus J. van Amerongen
Thiery Chapelle
Cornelis H. C. Dejong
Marc R. W. Engelbrecht
Michael F. Gerhards
Dirk J. Grünhagen
Thomas van Gulik
John J. Hermans
Koert P. de Jong
Joost M. Klaase
Niels F. M. Kok
Wouter K. G. Leclercq
Mike S. L. Liem
Krijn P. van Lienden
I. Quintus Molenaar
Ulf P. Neumann
Gijs A. Patijn
Arjen M. Rijken
Theo M. Ruers
Cornelis Verhoef
Johannes H. W. de Wilt
Geert Kazemier
Anne M. May
Cornelis J. A. Punt
Rutger-Jan Swijnenburg
Annals of Surgical Oncology, 2023, 30 : 5388 - 5389
[2] Feasibility of a national expert panel to determine resectability in patients with initially unresectable colorectal cancer liver metastases (CRLM).
Bolhuis, Karen
Huiskens, Joost
Dejong, Cornelis H. C.
Engelbrecht, Marc R. W.
Gerhards, Michael F.
Grunhagen, Dirk J.
de Jong, Koert P.
Kazemier, Geert
Klaase, Joost M.
Liem, Mike S. L.
van Lienden, Krijn P.
Molenaar, I. Quintus
Patijn, Gijs A.
Rijken, Arjen M.
Ruers, Theo M.
Swijnenburg, Rutger-Jan
Verhoef, Cornelis
de Wilt, Johannes H. W.
Punt, Cornelis J. A.
van Gulik, Thomas M.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[3] Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel
Huiskens, Joost
Bolhuis, Karen
Engelbrecht, Marc R. W.
De Jong, Koert P.
Kazemier, Geert
Liem, Mike S. L.
Verhoef, Cornelis
de Wilt, Johannes H. W.
Punt, Cornelis J. A.
van Gulik, Thomas M.
Van Amerongen, M. J.
Dejong, Cornelis H. C.
Gerhards, Michael F.
Grunhagen, Dirk
Heijmen, Linda
Hermans, John J.
Keijser, Astrid
Klaase, Joost M.
Van Lienden, Krijn P.
Molenaar, Quintus, I
Patijn, Gijs A.
Rijken, Arjen M.
Ruers, Theo M.
Swijnenbur, Rutger-Jan
van Tinteren, Harm
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (06) : 523 - +
[4] ASO Author Reflections: Towards Consensus on Resectability Assessments and Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases
Bond, Marinde J. G.
Punt, Cornelis J. A.
Swijnenburg, Rutger-Jan
ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (09) : 5386 - 5387
[5] ASO Author Reflections: Towards Consensus on Resectability Assessments and Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases
Marinde J. G. Bond
Cornelis J. A. Punt
Rutger-Jan Swijnenburg
Annals of Surgical Oncology, 2023, 30 : 5386 - 5387
[6] Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases: The randomized phase III CAIRO5 study of the Dutch Colorectal Cancer Group.
Huiskens, Joost
van Gulik, Thomas M.
van Lienden, Krijn P.
Engelbrecht, Marc R. W.
Meijer, Gerrit A.
van Grieken, Nicole C. T.
Schriek, Jonne
Keijser, Astrid
Molenaar, Linda Mol I. Quintus
Verhoef, Cornelis
de Jong, Koert P.
Dejong, Cornelis H. C.
Kazemier, Geert
Ruers, Theo
de Wilt, Johannes H. W.
van Tinteren, Harm
Punt, Cornelis J. A.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[7] Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases
Devaud, Nicolas
Kanji, Zaheer S.
Dhani, Neesha
Grant, Robert C.
Shoushtari, Hassan
Serrano, Pablo E.
Nanji, Sulaiman
Greig, Paul D.
McGilvray, Ian
Moulton, Carol-Anne
Wei, Alice
Gallinger, Steven
Cleary, Sean P.
HPB, 2014, 16 (05) : 475 - 480
[8] The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resection
Poston, G.
Adam, R.
Xu, J.
Byrne, B.
Esser, R.
Malik, H.
Wasan, H.
Xu, J.
EJSO, 2017, 43 (11): : 2001 - 2011
[9] Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?
Adam, Rene
Wicherts, Dennis A.
de Haas, Robbert J.
Ciacio, Oriana
Levi, Francis
Paule, Bernard
Ducreux, Michel
Azoulay, Daniel
Bismuth, Henri
Castaing, Denis
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (11) : 1829 - 1835
[10] Current treatment options for patients with initially unresectable isolated colorectal liver metastases
Kanat, Ozkan
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2016, 7 (01): : 9 - 14

← 1 2 3 4 5 →